Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

Recommendations for the management of secondary hyperparathyroidism in patients with CKD are shown in Box 1. Importantly, it is now recognized that vitamin D analog therapy enhances the survival ...

Rilparencel is ProKidney’s main candidate. It is intended as a therapy that stabilizes kidneys, making it potentially useful for CKD patients. We’ll have Rilparencel’s Phase 2 full data in ...

Adults in Tanzania living with HIV and taking tenofovir have a higher rate of chronic kidney disease vs. those without the ...

In keeping with current guidelines, either empagliflozin or dapagliflozin can be used for preventing AKI and CKD in patients with type 2 diabetes ... kidney failure requiring replacement therapy, ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Not having a formal CKD diagnosis significantly increases the ... Additionally, investigating the reasons behind low therapy persistence, such as with SGLT2-i, and finding ways to improve ...

The global continuous renal replacement therapy market is set for significant expansion, with projections indicating a surge ...